Connor, Clark & Lunn Investment Management Ltd. Aurinia Pharmaceuticals Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 650,191 shares of AUPH stock, worth $7.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

650,191

Previous 746,229 12.87%

Holding current value

$7.36 Million

Previous $6 Million 8.2%

% of portfolio

0.02%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$7.2 - $8.64 $691,473 - $829,768	-96,038 Reduced 12.87%	650,191 $5.51 Million
Q1 2025 May 12, 2025	BUY	$7.55 - $8.77 $1.43 Million - $1.66 Million	189,775 Added 34.1%	746,229 $6 Million
Q4 2024 Feb 10, 2025	BUY	$6.75 - $10.44 $689,816 - $1.07 Million	102,195 Added 22.5%	556,454 $5 Million
Q3 2024 Nov 08, 2024	BUY	$5.32 - $7.33 $2.42 Million - $3.33 Million	454,259 New	454,259 $3.33 Million
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $4.01 Million - $8.64 Million	-367,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$10.0 - $14.52 $689,120 - $1 Million	-68,912 Reduced 15.81%	367,000 $4.76 Million
Q1 2021 May 13, 2021	SELL	$12.3 - $18.73 $19.2 Million - $29.3 Million	-1,564,060 Reduced 78.2%	435,912 $5.67 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $4.91 Million - $6.09 Million	379,280 Added 23.4%	1,999,972 $27.6 Million
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $2.2 Million - $2.78 Million	166,792 Added 11.47%	1,620,692 $23.9 Million
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $5.31 Million - $6.9 Million	376,330 Added 34.92%	1,453,900 $23.6 Million
Q1 2020 May 13, 2020	BUY	$11.34 - $21.46 $12.2 Million - $23.1 Million	1,077,570 New	1,077,570 $15.6 Million

Others Institutions Holding AUPH

# of Institutions

243

Shares Held

62.3M

Call Options Held

1.03M

Put Options Held

665K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.61B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Aurinia Pharmaceuticals Inc. Transaction History